Key result
Sphenopalatine ganglion block significantly decreased the number of ectopic ventricular beats per hour (median 360 from 956 at baseline, P<0.001) and increased parasympathetic HRV parameters.
Why the study?
Sphenopalatine ganglion block is used for migraine, but its potential cardiovascular impact and effects on cardiac autonomic tone and ventricular arrhythmogenesis remained unclear.
Does sphenopalatine ganglion block improve heart rate variability and reduce premature ventricular contractions in patients with migraine or PVCs?
RCT (n=64)
1:1
Does sphenopalatine ganglion block improve heart rate variability and reduce premature ventricular contractions in patients with migraine or PVCs?
p-value: p=<0.001
Sphenopalatine ganglion block transiently increases parasympathetic tone and significantly reduces the burden of premature ventricular contractions.
Sphenopalatine ganglion block was associated with fewer ventricular ectopy; leaves open clinical utility pending randomized trials.
Background: Autonomic modulation is used for treating various cardiovascular diseases, such as cardiac arrhythmias. Sphenopalatine ganglion (SPG) block is an easy, non-invasive therapy for migraine with a potential cardiovascular impact that remains unclear. In this study, we sought to assess the effect of SPG block on cardiac autonomic tone, as expressed by heart rate variability (HRV), and on ventricular arrhythmogenesis. Methods: Forty patients (14 male and 26 female) suffering from migraine were randomized by 1:1 to SPG block or placebo (controls) and HRV parameters were evaluated 1 hour before and hourly after the intervention. Twenty-four additional patients (11 men and 13 women) with premature ventricular contractions (PVCs) from the right ventricular outflow tract underwent the same randomization and the number of PVCs was assessed during 1 hour before and every hour after treatment. Values were summarized as median (1st–3rd quartile). Results: During the first four hours after SPG block, an increase in mean RR [883 (IQR, 869–948) vs. 839 (IQR, 806–887) ms at baseline, P<0.01], SDNN [64 (IQR, 59–69) vs. 51 (IQR, 47–55) ms, P<0.01], SDANN [39 (IQR, 36–43) vs. 27 (IQR, 22–29) ms, P<0.01], ASDNN [51 (IQR, 47–53) vs. 40 (IQR, 37–44) ms, P<0.01], rMSSD [30 (IQR, 27–32) vs. 25 (IQR, 23–27) ms, P<0.01], VLF [26 (IQR, 24–29) vs. 23 (IQR, 22–25) ms2, P<0.01] and HF [14 (IQR, 11–16) vs. 11 (IQR, 9–12) ms2, P<0.01], along with a decrease in LF/HF ratio [1.7 (IQR, 1.4–1.9) vs. 2.0 (IQR, 1.7–2.5), P<0.01] was observed in patients with migraine. In patients with PVCs, the number of ectopic ventricular beats per hour was decreased for the first five hours following SPG block [360 (IQR, 264–850) from 956 (IQR, 545–1,412), P<0.001]. No such differences were observed in controls. Conclusions: SPG block is associated with a transient increase in those HRV parameters that mainly express parasympathetic activity. It is also followed by a significant decrease in ventricular arrhythmic burden. These findings imply an effect on cardiac autonomic tone with a potential favorable clinical impact on arrhythmogenesis.
No takes yet. Share an insight, caveat, or question.
Katsaras et al. (2018) conducted an RCT in Migraine and premature ventricular contractions (n=64). Sphenopalatine ganglion (SPG) block vs. Placebo was evaluated on Number of ectopic ventricular beats per hour (p=<0.001). Sphenopalatine ganglion block significantly decreased the number of ectopic ventricular beats per hour (median 360 from 956 at baseline, P<0.001) and increased parasympathetic HRV parameters.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: